Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Submitted by
admin
on November 20, 2010 - 1:17pm
Source:
Medical News Today
News Tags:
Aeterna Zentaris
AEZS-129
AEZS-132
cancer
melanoma
lung cancer
prostate cancer
colon cancer
breast cancer
endometrial cancer
Headline:
Aeterna Zentaris Presents Encouraging Preclinical Data On Two Novel Orally Active Anti-Cancer Compounds At Major Conference In Germany
Do Not Allow Advertisers to Use My Personal information
